Associated Banc-Corp Reports Soaring 2025 Net Income and EPS, Authorizes $100M Stock Repurchase
ASB sits 50% above its 52-week low of $18.32.
Summary
Associated Banc-Corp reported substantially improved financial results for 2025, with net income and EPS surging, and announced a new $100 million common stock repurchase authorization.
Key Events · Earnings and Guidance · ASB
-
Exceptional 2025 Financial Performance
Net income available to common equity surged to $463.3 million in 2025, a significant increase from $111.6 million in 2024. Diluted earnings per share (EPS) rose to $2.77 from $0.72 in the prior year.
-
Strong Profitability Metrics
Return on average tangible common equity (ROATCE) dramatically improved to 13.63% in 2025, up from 3.99% in 2024, reflecting enhanced profitability and efficiency.
-
New $100 Million Share Repurchase Program
The Board of Directors authorized a new program to repurchase up to $100 million of common stock, indicating confidence in the company's valuation and a commitment to returning capital to shareholders.
-
Improved Asset Quality
Total nonaccrual loans decreased by 19% to $100.4 million, and nonperforming assets (NPAs) to total assets improved to 0.29% from 0.34% in 2024.
Analysis · ASB · Finance
Associated Banc-Corp's 2025 annual report reveals a significant financial rebound, with net income and EPS dramatically increasing year-over-year. This strong performance, driven by improved net interest income and the absence of prior year's nonrecurring losses, signals robust operational health. The new $100 million share repurchase authorization further demonstrates management's confidence in the company's valuation and commitment to shareholder returns. While the increase in uninsured deposits warrants monitoring, the overall liquidity position and capital ratios remain strong. The ongoing American National acquisition is a key strategic move that will shape future performance.
At the time of this filing, ASB was trading at $27.56 on NYSE in the Finance sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $18.32 to $29.52. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.